ena-STUDY-UNIVERSITY OF NEW SOUTH WALES-15-10-2021-04:26:38:973-193
Oral lyophilised faecal microbiota transplantation in ulcerative colitis ITS
We assess the microbiome changes in patients undergoing faecal microbiota transplantation for ulcerative colitis. The fungal component of the microbiota was amplified using ITS amplicon sequencing (ITS2 region).We report outcomes our randomised, blinded, placebo-controlled clinical trial of patients who received lyophilised FMT for ulcerative colitis and characterise bacteriome and mycobiome changes associated with therapeutic outcomes following FMT.
We assess the microbiome changes in patients undergoing faecal microbiota transplantation for ulcerative colitis. The fungal component of the microbiota was amplified using ITS amplicon sequencing (ITS2 region).We report outcomes our randomised, blinded, placebo-controlled clinical trial of patients who received lyophilised FMT for ulcerative colitis and characterise bacteriome and mycobiome changes associated with therapeutic outcomes following FMT.